Well Differentiated Thyroid Cancer
نویسندگان
چکیده
منابع مشابه
Thyroid hormone replacement one day before 131I therapy in patients with well-differentiated thyroid cancer
Objective: The current study aimed to determine the efficacy of radioiodine-131 (131I) ablation therapy with thyroid hormone replacement one day before 131I administration in patients with well-differentiated thyroid cancer (DTC). Methods: This retrospective study included 29 patients who underwent 131I therapies twice for DTC during 6-12 months. Since all the patients obviously had residual l...
متن کاملCompletion Thyroidectomy for Well-differentiated Thyroid Cancer
Copyright: © 2012 Barczyński M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
متن کاملEpigenetic Alterations in well-Differentiated Thyroid Cancer
Genetic and epigenetic alterations have been associated with cancer development and progression. Important epigenetic modifications include posttranslational histone changes, covalent modifications of DNA bases and non-coding RNAs. Welldifferentiated thyroid carcinomas comprise papillary and follicular carcinomas, the most common subtypes. Methylation of thyroid-specific genes, including NIS an...
متن کاملFactors affecting discharge time of well differentiated thyroid cancer patients receiving 131I therapy: Five years’ experience
Introduction:The post-surgical management of patients with differentiated thyroid cancer include ablation of remnant local and distant metastatic tissues with 131I therapy, which accentuates isolation of the patient in order to avoid unnecessary radiation exposure to the care givers, general public and the environment. The duration of isolation is subject to the redu...
متن کاملthyroid hormone replacement one day before 131i therapy in patients with well-differentiated thyroid cancer
objective: the current study aimed to determine the efficacy of radioiodine-131 (131i) ablation therapy with thyroid hormone replacement one day before 131i administration in patients with well-differentiated thyroid cancer (dtc). methods: this retrospective study included 29 patients who underwent 131i therapies twice for dtc during 6-12 months. since all the patients obviously had residual l...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Scandinavian Journal of Surgery
سال: 2004
ISSN: 1457-4969,1799-7267
DOI: 10.1177/145749690409300403